Robert Andrade, Chief Financial Officer at Fennec Pharmaceuticals, sold FENC on Aug 27, 2026
Data as of Oct 27
▼ SELL$884K75,000 shares at $11.78Robert Andrade Chief Financial OfficerFENC Fennec Pharmaceuticals Inc.
- Traded
- Aug 27, 2026
- Disclosed
- Aug 28, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
FENC since disclosure
−13.4%
after the sale
Similar stocks (XLV) since disclosure
+4.7%
XLV — its sector index fund
Change in closing price from Aug 28, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.